NCT05681767 Motivational Multicomponent Lifestyle Interventions as a Supportive Treatment for Depression in Primary Health Care
| NCT ID | NCT05681767 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kuopio University Hospital |
| Condition | Depression |
| Study Type | INTERVENTIONAL |
| Enrollment | 210 participants |
| Start Date | 2022-11-21 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 210 participants in total. It began in 2022-11-21 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators aim to examine whether a motivational multicomponent lifestyle intervention as a supportive treatment for depression has a beneficial effect on recovery from depression in a primary health care setting.
Eligibility Criteria
Inclusion Criteria: * adults ≥ 18 years * depression (ICD-10, F32-F33) * Beck Depression Inventory (BDI-1A) ≥ 10 points * the initiation of treatment in a primary health care center Exclusion Criteria: * bipolar disorder * psychosis * substance abuse * pregnancy or lactation * a long-term rehabilitative psychotherapy.
Contact & Investigator
Pekka Mäntyselkä
PRINCIPAL INVESTIGATOR
University of Eastern Finland
Frequently Asked Questions
Who can join the NCT05681767 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05681767 currently recruiting?
Yes, NCT05681767 is actively recruiting participants. Contact the research team at pekka.mantyselka@uef.fi for enrollment information.
Where is the NCT05681767 trial being conducted?
This trial is being conducted at Kuopio, Finland.
Who is sponsoring the NCT05681767 clinical trial?
NCT05681767 is sponsored by Kuopio University Hospital. The principal investigator is Pekka Mäntyselkä at University of Eastern Finland. The trial plans to enroll 210 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.